You are here: Industry Insights > NHS

News List

Novartis’ ‘life-changing’ Ilaris set for NHS funding pharmatimes
March 06, 2020
The NHS has revealed plans to fund Novartis’ Ilaris (canakinumab), for people with rare conditions causing repeated bouts of fever, joint pains and swelling.
UK accounts for 12 percent of global cell and gene therapy clinical trials europeanpharmaceuticalreview
January 19, 2020
New research has found that the cell and gene therapy clinical environment in the UK has encouraged commercial sponsorship from around the world.
Novartis and NHS partner to improve manufacture of oligonucleotides europeanpharmaceuticalreview
January 14, 2020
A partnership between Novartis and NHS England includes a proposal to investigate processes that can increase the scale and efficacy of oligonucleotide manufacture.
Treatment for hyperkalaemia recommended by NICE for NHS europeanpharmaceuticalreview
December 19, 2019
NICE has recommended patients in England have access to a new treatment option for treating hyperkalaemia (raised serum potassium levels) in adults.
Shionogi’s thrombocytopenia drug secures approval for use on NHS pharmaceutical-technology
December 16, 2019
Japanese company Shionogi has received approval for Mulpleo (lusutrombopag) drug on the National Health Service (NHS) in England ...
NICE recommends voretigene neparvovec for use on NHS europeanpharmaceuticalreview
September 05, 2019
The voretigene neparvovec gene therapy treatment has been highlighted in draft guidance by NICE for availability on the NHS.
Biologics and generics reported to save NHS £700m europeanpharmaceuticalreview
September 03, 2019
An NHS-wide plan to use more generic and biologic products has reportedly saved the healthcare provider £700 million since 2016.
NHS England expands funding of Roche’s Hemlibra for haemophilia A pharmaceutical-technology
August 23, 2019
NHS England has announced it will reimburse Hemlibra (emicizumab) for severe congenital haemophilia A patients without clotting protein factor VIII inhibitors.
Drug supplier Aspen to pay NHS £8m after competition probe europeanpharmaceuticalreview
August 16, 2019
The CMA alleges that Aspen broke competition law, prompting the drug supplier to offer a payment and other compensations to the NHS.
NICE releases draft guidance for using cannabis-based medicinal products europeanpharmaceuticalreview
August 12, 2019
The NICE and NHS have announced their draft recommendations for the prescribed use of cannabis-based treatments.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 44 45 Next page